NFG
INSY

Next Financial Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Next Financial Group’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$1K – 2453
2019
Q1 		$1K Hold
200
– – ﹤0.01% 1611
2018
Q4 		$1K Hold
200
– – ﹤0.01% 1926
2018
Q3 		$2K Buy
+200
New +$1.59K ﹤0.01% 1355
2017
Q4 		– Sell
-380
Closed -$3K – 1652
2017
Q3 		$3K Sell
380
-400
-51% -$4.13K ﹤0.01% 1573
2017
Q2 		$10K Sell
780
-1,000
-56% -$11.8K ﹤0.01% 1331
2017
Q1 		$20K Sell
1,780
-35
-2% -$373 0.01% 1062
2016
Q4 		$17K Hold
1,815
– – ﹤0.01% 1446
2016
Q3 		$21K Buy
1,815
+1,635
+908% +$24.9K ﹤0.01% 1349
2016
Q2 		$2K Hold
180
– – ﹤0.01% 1624
2016
Q1 		$2K Hold
180
– – ﹤0.01% 1586
2015
Q4 		$5K Hold
180
– – ﹤0.01% 1412
2015
Q3 		$5K Hold
180
– – ﹤0.01% 1450
2015
Q2 		$6K Hold
180
– – ﹤0.01% 1450
2015
Q1 		$5K Hold
180
– – ﹤0.01% 1505
2014
Q4 		$4K Hold
180
– – ﹤0.01% 1605
2014
Q3 		$3K Hold
180
– – ﹤0.01% 2259
2014
Q2 		$3K Buy
+180
New +$2.91K ﹤0.01% 1037

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Next Financial Group's INSY Position: Q2 2019 in Review

Next Financial Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 200 shares — an estimated $1K sold.

Next Financial Group first reported a position in INSY in Q2 2014 and held it in 17 quarters. The position peaked at $21K in Q3 2016. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Next Financial Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Next Financial Group sold 200 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $1K.
  • Next Financial Group first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 17 quarters.
  • Next Financial Group's Insys Therapeutics, Inc. position peaked at $21K in Q3 2016.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Next Financial Group's 13F filing for Q2 2019, filed 16 Jul 2019.